跳到正文

Purdue Pharma

争议事件

以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。

返回词条共 5 条

  1. 2024

    最高法院关于萨克勒免责的裁决

    最高法院否决了原破产和解,因为该和解将在未经受影响索赔人同意的情况下释放对萨克勒家族成员的索赔。该裁决要求进行修订后的重组程序。

  2. 2020

    联邦刑事和解

    普渡同意对涉及阿片类药物营销及相关行为的联邦刑事指控认罪,并与司法部达成重大民事和刑事和解。

  3. 2019

    阿片类药物诉讼与破产

    针对普渡的数千项阿片类药物相关索赔导致公司寻求第11章破产保护。该破产案成为关于企业问责以及利用破产解决对非破产所有者索赔的重大争议。

  4. 2019

    恩西尼塔斯市起诉阿片类药物制造商和分销商

    提起诉讼

    恩西尼塔斯市对阿片类药物行业的多家公司及相关方提起诉讼,指称制造商和分销商的行为导致医生开具相关药物,并忽视了向消费者警示其成瘾性。诉讼列明 Teva Pharmaceutical Industries USA Inc.、Janssen Pharmaceuticals Inc.、AmerisourceBergen Corp. 以及 Purdue Pharma 的所有者 Sackler 家族。

    当事方说明的目的. 追回该市及其居民因阿片类药物危机承担的费用和税收资源。

    品牌回应

    • 否认 — Publicis Health

      In a statement, a spokesperson with Publicis Health said the lawsuit is “completely without basis.”

    来源摘录

    • The parties named in the suit include Teva Pharmaceutical Industries USA Inc., Janssen Pharmaceuticals Inc., the AmerisourceBergen Corp. and the Sackler family, the owners of oxycontin manufacturer Purdue Pharma.
    • The city of Encinitas announced Thursday that it filed a lawsuit against multiple companies and parties in the opioid manufacturing industry, arguing that the city is entitled to economic and health and welfare damages due to the ongoing opioid crisis.
    • “This lawsuit will seek to recover costs and tax resources taken from the City and its citizens due to the bad acts of the manufacturers and distributors of opioids who caused this ongoing crisis,” said Robins Kaplan attorney Roman Silberfeld.
  5. 2007

    奥施康定错误品牌认罪

    普渡制药有限合伙公司对联邦错误品牌指控认罪,指控基于其将奥施康定描述为比其他止痛药更不易成瘾、更不易滥用、更不易引起戒断。